ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
15
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,373
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Multi-center randomized placebo controlled phase II/III trial of CD8(+) tumor infiltrating lymphocyte therapy (CD8(+)TIL)/recombinant interleukin-2 (IL-2) in metastatic renal cell carcinoma (MRCC)
Author(s):
R Figlin
,
J. Thompson
,
C. Roudet
,
P Lange
,
A. S. Belldegrun
Publication date:
1998
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
,
Medicine
Comments
Comment on this article
Sign in to comment
Similar content
1,373
Håndbog for pårørende – til personer med hjerneskade. [Handbook for relatives of persons with brain injury]
Authors:
B. Wiwe L.
Patient Preference for Tivozanib Hydrochloride or Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma (MRCC): Taurus Study
Authors:
B Escudier
,
L Steelman
,
D Cesic
…
Sa nei til Nordic Light (Said no to Nordic Light)
Authors:
S. Joakimsen T.
See all similar
Cited by
1
Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial
Authors:
A Ravaud
,
N Trufflandier
,
J M Ferrière
…
See all cited by